Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy [6]

Leukemia

Volumn 20, Issue 7, 2006, Pages 1298-1300

  Hambach, L ^a   Nijmeijer, B A ^a   Drabbels, J J M ^a   Falkenburg, J H F ^a   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN; TUMOR ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ANTIGEN PRESENTATION; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 7; CHROMOSOME ABERRATION; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENETIC CODE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOTHERAPY; ISOCHROMOSOME; KARYOTYPING; LETTER; MOLECULAR MECHANICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 33745190326     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404237     Document Type: Letter

References (8)

1. van der Harst D, Goulmy E, Falkenburg J, Kooij-Winkelaar Y, van Luxemburg-Heijs S, Goselink H et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 1994; 83: 1060-1066.
2. Hambach L, Goulmy E. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005; 17: 202-210.
3. Yunis J, Brunning R. Prognostic significance of chromosomal abnormalities in acute leukemias and myelodysplastic syndromes. Clin Haematol 1986; 15: 597-620.
4. den Haan J, Meadows L, Wang W, Pool J, Blokland E, Bishop T et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054-1057.
5. Pierce R, Field E, Mutis T, Golovina T, von Kap-Herr C, Wilke M et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223-3230.
6. Brouwer R, van der Heiden P, Schreuder G, Mulder A, Datema G, Anholts J et al. Loss or Downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by Interferon. Hum Immunol 2002; 63: 200-210.
7. Miyazaki M, Akatsuka Y, Nishida T, Fuji N, Hiraki A, Ikeda K et al. Potential, limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clin Immunol 2003; 107: 198-201.
8. van Els C, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen P et al. Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance. Immunogenetics 1992; 35: 161-165.